SWK Holdings Corporation is an investment firm specializing in the acquisition and management of portfolios within the life sciences sector, targeting high-risk-adjusted returns through innovative financial solutions tailored for transformative therapies. The firm strategically issues senior notes, notably its 9.00% Senior Notes due 2027, to fund emerging opportunities in the healthcare market. With a robust investment strategy and deep industry knowledge, SWK Holdings is well-equipped to generate substantial value for investors while adeptly navigating the complexities of a dynamic healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting